USD 6.3
(0.0%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | -5.91 Billion | 5.7 Billion | 320.85 Million | -4.84 Billion | 244.14 Million | 145.96 Million |
Net Income | 545 Million | 331 Million | 336.79 Million | 393.39 Million | 132.74 Million | 264.41 Million |
Depreciation & Amortization | 111.79 Million | -68.46 Million | -68.44 Million | -75.22 Million | -49.7 Million | -13.33 Million |
Deferred income taxes | - | -7 Million | -4.5 Million | -2.99 Million | -3.29 Million | -3.99 Million |
Stock-based compensation | 24.7 Million | 7 Million | 4.5 Million | 3 Million | 3.3 Million | 4 Million |
Change in working capital | -8.16 Billion | -111.62 Million | -78.66 Million | -5.28 Billion | -54.66 Million | -192.63 Million |
Other non-cash items | -107.39 Million | 5.55 Billion | 131.17 Million | 125.22 Million | 215.77 Million | 87.5 Million |
Investing Cash Flow | -52.1 Million | -597.5 Million | -8.3 Billion | 1.74 Billion | -30.22 Million | -27.08 Million |
Investments in PPE | -27.2 Million | -30.6 Million | -10 Million | -15.76 Million | -23.68 Million | -11.36 Million |
Acquisitions | 200 Thousand | -4 Million | 5.1 Million | 5.63 Million | 2.89 Million | 561.39 Thousand |
Investment purchases | - | -418.04 Million | -4.44 Billion | -29.42 Million | -43.92 Million | -47.22 Million |
Sales/Maturities of investments | - | 1.83 Billion | 49.54 Million | 1.78 Billion | 34.49 Million | 30.94 Million |
Other Investing Activities | -24.9 Million | -1.97 Billion | -3.9 Billion | 0.20 | 0.72 | 0.82 |
Financing Cash Flow | -411.3 Million | -340.6 Million | 5.54 Billion | 7.53 Billion | -35.25 Million | -221.26 Million |
Debt repayment | -25 Million | -92.77 Million | -38.02 Million | -66.14 Million | -7.22 Million | -19.5 Million |
Dividends payments | -351 Million | -290.7 Million | -213.7 Million | -105.3 Million | -277.4 Million | -288.7 Million |
Common Stock Repurchased | -332.4 Million | 185.54 Million | -6 Million | -2.4 Million | -2.96 Million | -1.2 Million |
Common Stock Issuance | 500 Thousand | 600 Thousand | 414.01 Thousand | 79.8 Million | 203.72 Million | 842.09 Thousand |
Other Financing Activities | 296 Million | -143.27 Million | 5.73 Billion | 7.59 Billion | -37.79 Million | 1.2 Million |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | -8.16 Billion | -111.62 Million | -78.66 Million | -5.28 Billion | -54.66 Million | -192.63 Million |
Cash at beginning of period | 8.31 Billion | 3.55 Billion | 7.08 Billion | 1.18 Billion | 922 Million | 1.06 Billion |
Cash at end of period | 1.93 Billion | 8.31 Billion | 3.55 Billion | 7.08 Billion | 1.18 Billion | 922 Million |
Capital Expenditure | -27.2 Million | -30.6 Million | -10 Million | -15.76 Million | -23.68 Million | -11.36 Million |
Effect of forex changes on cash | - | -1.59 Billion | -1.09 Billion | 1.47 Billion | 80.83 Million | -43.51 Million |
Net cash flow / Change in cash | -6.37 Billion | 4.76 Billion | -3.53 Billion | 5.9 Billion | 259.5 Million | -145.9 Million |
Free Cash Flow | -5.94 Billion | 5.67 Billion | 310.85 Million | -4.86 Billion | 220.45 Million | 134.59 Million |
Breakdown | 2024 Q4 | 2024 FY | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 175.11 Million | - | 192.18 Million | 165.16 Million | 331 Million | 169.66 Million |
Depreciation & Amortization | 36.32 Million | - | 39 Million | 31.03 Million | -68.46 Million | 38.29 Million |
Deferred income taxes | - | - | - | - | -7 Million | - |
Stock-based compensation | - | - | - | - | 7 Million | - |
Change in working capital | 1.17 Billion | - | -1.05 Billion | 289.51 Million | -111.62 Million | -410.4 Million |
Other non-cash items | -88.39 Million | - | 217.03 Million | 145.72 Million | 5.55 Billion | 55.6 Million |
Investing Cash Flow | -895.71 Million | -52.1 Million | -3.12 Billion | -959.7 Million | -597.5 Million | 2.15 Billion |
Investments in PPE | -7.46 Million | -27.2 Million | -10.89 Million | -13.65 Million | -30.6 Million | -6.88 Million |
Acquisitions | - | 200 Thousand | - | - | -4 Million | 68.13 Thousand |
Investment purchases | 852.98 Million | - | -3.51 Billion | -399.26 Million | -418.04 Million | -19.21 Million |
Sales/Maturities of investments | 25.19 Million | - | 27.29 Million | 263.13 Million | 1.83 Billion | 1.6 Billion |
Other Investing Activities | -26.59 Million | - | 374.7 Million | -809.92 Million | -1.97 Billion | 569.36 Million |
Financing Cash Flow | -2.26 Billion | -411.3 Million | 1.44 Billion | 541.12 Million | -340.6 Million | 1.16 Billion |
Debt repayment | -1.5 Billion | -25 Million | -17.35 Million | - | -92.77 Million | - |
Dividends payments | -113.18 Million | -351 Million | -123.35 Million | -107.95 Million | -290.7 Million | -87.62 Million |
Common Stock Repurchased | -221.57 Million | -332.4 Million | - | - | 185.54 Million | - |
Common Stock Issuance | 133.32 Thousand | 500 Thousand | 204.23 Thousand | 199.8 Thousand | 600 Thousand | 204.41 Thousand |
Other Financing Activities | -429.69 Million | 296 Million | 1.54 Billion | 648.88 Million | -143.27 Million | 1.25 Billion |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 1.17 Billion | - | - | - | -111.62 Million | - |
Cash at beginning of period | - | 8.31 Billion | - | - | 3.55 Billion | - |
Cash at end of period | -1.93 Billion | 1.93 Billion | -2.36 Billion | 150.78 Million | 8.31 Billion | 3.09 Billion |
Capital Expenditure | -7.46 Million | -27.2 Million | -10.89 Million | -13.65 Million | -30.6 Million | -6.88 Million |
Effect of forex changes on cash | - | - | - | - | -1.59 Billion | - |
Net cash flow / Change in cash | -1.93 Billion | -6.37 Billion | -2.36 Billion | 150.78 Million | 4.76 Billion | 3.09 Billion |
Free Cash Flow | 1.22 Billion | -5.94 Billion | -693.71 Million | 555.71 Million | 5.67 Billion | -230.3 Million |
IMTV
298040
ANGELONE
PCIP
AVVH
1112